310 related articles for article (PubMed ID: 21873467)
1. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.
Mazur PK; Siveke JT
Gut; 2012 Oct; 61(10):1488-500. PubMed ID: 21873467
[TBL] [Abstract][Full Text] [Related]
2. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
[TBL] [Abstract][Full Text] [Related]
3. Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas.
Hidalgo M; Von Hoff DD
Clin Cancer Res; 2012 Aug; 18(16):4249-56. PubMed ID: 22896691
[TBL] [Abstract][Full Text] [Related]
4. Modeling pancreatic cancer in mice for experimental therapeutics.
Mallya K; Gautam SK; Aithal A; Batra SK; Jain M
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188554. PubMed ID: 33945847
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
Mardin WA; Mees ST
Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
[TBL] [Abstract][Full Text] [Related]
6. The mighty mouse: genetically engineered mouse models in cancer drug development.
Sharpless NE; Depinho RA
Nat Rev Drug Discov; 2006 Sep; 5(9):741-54. PubMed ID: 16915232
[TBL] [Abstract][Full Text] [Related]
7. Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer.
Funel N; Giovannetti E; Pollina LE; del Chiaro M; Mosca F; Boggi U; Campani D
Expert Rev Mol Diagn; 2011 Sep; 11(7):695-701. PubMed ID: 21902531
[TBL] [Abstract][Full Text] [Related]
8. Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope?
Partensky C
Pancreas; 2013 Jul; 42(5):729-39. PubMed ID: 23648843
[TBL] [Abstract][Full Text] [Related]
9. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
Grippo PJ; Fitchev PS; Bentrem DJ; Melstrom LG; Dangi-Garimella S; Krantz SB; Heiferman MJ; Chung C; Adrian K; Cornwell ML; Flesche JB; Rao SM; Talamonti MS; Munshi HG; Crawford SE
Gut; 2012 Oct; 61(10):1454-64. PubMed ID: 22234980
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer: translating lessons from mouse models and hereditary syndromes.
Wescott MP; Rustgi AK
Cancer Prev Res (Phila); 2008 Dec; 1(7):503-6. PubMed ID: 19138999
[TBL] [Abstract][Full Text] [Related]
11. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.
Singh P; Srinivasan R; Wig JD
Pancreas; 2011 Jul; 40(5):644-52. PubMed ID: 21673535
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1: a marker for pancreatic cancer diagnosis.
Tanase CP
Expert Rev Mol Diagn; 2008 Jul; 8(4):395-404. PubMed ID: 18598222
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers of early pancreatic cancer.
Goggins M
J Clin Oncol; 2005 Jul; 23(20):4524-31. PubMed ID: 16002843
[TBL] [Abstract][Full Text] [Related]
14. Ductal pancreatic cancer in humans and mice.
Tuveson DA; Hingorani SR
Cold Spring Harb Symp Quant Biol; 2005; 70():65-72. PubMed ID: 16869739
[TBL] [Abstract][Full Text] [Related]
15. Early requirement of Rac1 in a mouse model of pancreatic cancer.
Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
[TBL] [Abstract][Full Text] [Related]
16. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.
Yamahatsu K; Matsuda Y; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2012 May; 40(5):1345-57. PubMed ID: 22246533
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of biological markers in Pancreatic Ductal Adenocarcinoma.
Giovinazzo F; Turri G; Zanini S; Butturini G; Scarpa A; Bassi C
Surg Oncol; 2012 Dec; 21(4):e171-82. PubMed ID: 22981281
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation in pancreatic cancer: protocols for the isolation of DNA and bisulfite modification.
Biewusch K; Heyne M; Grützmann R; Pilarsky C
Methods Mol Biol; 2012; 863():273-80. PubMed ID: 22359299
[TBL] [Abstract][Full Text] [Related]
19. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
